|
- OpenEvidence
OpenEvidence has signed content agreements with NEJM, JAMA, NCCN, Wiley, Cochrane, and more An Official AI Partner of The New England Journal of Medicine OpenEvidence content includes figures, tables, multimedia and full-text clinical findings from The New England Journal of Medicine
- OpenEvidence - Wikipedia
OpenEvidence is an American artificial intelligence company that develops a medical search engine used by physicians for clinical decision support The company was founded in 2022 by entrepreneur Daniel Nadler and is headquartered in Miami, Florida
- www. openevidence. org
www openevidence org
- OpenEvidence - App Store
OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the world–used daily, on average, by over 40% of physicians in the United States, spanning more than 10,000 hospitals and medical centers nationwide
- OpenEvidence launches Coding Intelligence™ to help physicians capture . . .
MIAMI, March 26, 2026 PRNewswire -- OpenEvidence, the most widely used medical AI and clinical decision-support platform among U S physicians, today announced the launch of Coding Intelligence
- OpenEvidence: How AI is Transforming Clinical Research
OpenEvidence has announced the wide release of OpenEvidence DeepConsult, described as the first AI agent purpose-built for physicians The system uses reasoning models to autonomously analyse and cross-reference hundreds of peer-reviewed medical studies in parallel, providing comprehensive research reports that would otherwise require months of
- Healthcare AI startup OpenEvidence raises $75M in Sequoia-led round to . . .
Founded in 2021, OpenEvidence is focused on organizing and expanding access to medical knowledge, offering an AI assistant that helps doctors make informed decisions at the point of care
- OpenEvidence: ChatGPT for Doctors 2026 Plans and Strategic Outlook
OpenEvidence entered 2026 on an extraordinary growth arc In January 2026, the Miami-based company closed a $250 Million Series D led by Thrive Capital and DST Global, doubling its valuation to
|
|
|